Research - Calgary, Alberta, Canada
Our gene therapy platform, AAV-mAb, is designed to make and release proprietary, specific monoclonal antibodies (mAb) against healthcare-acquired and pandemic infections.
Apache
WordPress.org
Google Tag Manager
Typekit
Mobile Friendly